ClinConnect ClinConnect Logo
Search / Trial NCT07115381

A Study on the Intervention Effect of Therapeutic Horticulture Based on the Healing System on Non-suicidal Self-injury in Adolescent Patients With Depression

Launched by LEI HUANG · Aug 4, 2025

Trial Information

Current as of August 19, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This study is exploring whether therapeutic gardening can help teenagers with depression who hurt themselves without intending to die (called non-suicidal self-injury). Therapeutic gardening involves activities like planting and caring for plants, which may provide emotional benefits and improve things like mood, sleep, feelings of loneliness, and confidence. The goal is to see if these gardening activities can reduce self-harm and help these young people feel better emotionally.

To join this study, participants need to be diagnosed with moderate to severe depression and have a history of non-suicidal self-injury, based on standard mental health guidelines. Both the teens and their guardians must agree to take part, and the participants should be able to read, write, and communicate normally. People currently at risk of suicide or those who have recently had certain medical treatments (like electroconvulsive therapy) cannot join. If eligible, participants will take part in gardening sessions designed to promote healing and emotional growth. This study has not yet started recruiting participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • It meets the diagnostic criteria for moderate to severe depression in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
  • It meets the diagnostic criteria for non-suicidal self-harm in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
  • It meets the diagnostic criteria for non-suicidal self-harm in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
  • The patients and their guardians gave informed consent and voluntarily participated in this study.
  • Have normal reading comprehension ability, language communication ability and writing ability.
  • Exclusion Criteria:
  • Have normal reading comprehension ability, language communication ability and writing ability.
  • Have normal reading comprehension ability, language communication ability and writing ability.
  • Those who have received electroconvulsive therapy without convulsions within the past six months or are currently undergoing such treatment.
  • Those who have received electroconvulsive therapy without convulsions within the past six months or are currently undergoing such treatment.
  • Those at risk of suicide and those who commit suicide.

About Lei Huang

Lei Huang is a clinical trial sponsor with expertise in overseeing and managing clinical research studies. Committed to advancing medical knowledge and improving patient outcomes, Lei Huang ensures adherence to regulatory standards and ethical guidelines throughout the research process. With a focus on fostering collaboration among investigators and stakeholders, Lei Huang plays a pivotal role in the successful execution and integrity of clinical trials.

Locations

Guangzhou, , China

Patients applied

0 patients applied

Trial Officials

Zhichun Xia

Study Director

The Affiliated Brain Hospital of Guangzhou Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported